Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Canadian Pharmaceutical Giant Apotex Inc. Plans US Hub In Miramar, Florida

03/08/2017
Apotex Inc., the largest Canadian owned pharmaceutical company, plans a $184 million U.S. expansion, including the development of an R&D center, along with an advanced manufacturing and packaging facility in Miramar, Florida.

According to company officials, the hub in Broward County will also serve as the U.S. headquarters for Apotex Corp. and the U.S. offices for Apobiologix. This move marks the largest investment that Apotex has made in the U.S. and will result in at least 150 new full-time positions.

The company said it chose this strategic location to facilitate more efficient expansion and service of the critical U.S. market, to enhance access to Latin America, and to capture the benefits of Broward County's business environment. When completed, this facility will be one of the largest manufacturing projects in South Florida. The site will also house the packaging operations of Aveva Drug Delivery Systems. Construction on the building is underway and expected to be completed in early 2019.

"Expanding our footprint in the U.S. is a central component of our strategy for global growth and reflects the critical importance of the U.S. and Latin American markets to our success, as well as our confidence in the future of the American manufacturing and biopharmaceutical sector," said Apotex CEO & President, Dr. Jeremy B. Desai.

"With generic and biosimilar medicines playing an increasingly vital role in reducing the cost of drugs, Apotex will continue making strategic investments in R&D and American manufacturing to deliver high-quality, affordable medicine to patients, healthcare providers and stakeholders in the U.S. and around the world. In addition, due to U.S. regulations, we are only permitted to manufacture controlled substances in the U.S. when serving this market, so expansion in Canada was not feasible,” he added.

"Over the past several years, Greater Fort Lauderdale/Broward County has worked to develop this region into the destination of choice for the most advanced companies in the biomedical field," said Bob Swindell, President & CEO of the Greater Fort Lauderdale Alliance. "We congratulate Apotex on this bold investment and commit our ongoing support in the company's continued growth and success."

Broward County Mayor Barbara Sharief added, "As the home to a thriving community of innovative, purpose-driven companies and dedicated researchers, we are incredibly proud of the role that Broward County plays in supporting the development of life saving treatments for vulnerable patients throughout the world. We welcome Apotex as a new member of the Broward County family and look forward to a long and fruitful relationship."

Miramar Mayor Wayne Messam said, "With one of the fastest growing economies in the nation, Miramar remains an attractive city for companies to grow and prosper. Our city has been intentional in attracting target market firms like Apotex. Miramar is so excited about the opportunity to partner with Apotex in their expansion. It will create hundreds of high paying jobs for our city and residents and will help to fuel an already thriving economic position for Miramar and the region."

Exclusive Research